Stay updated on Menin Inhibitor Combo in AML Clinical Trial
Sign up to get notified when there's something new on the Menin Inhibitor Combo in AML Clinical Trial page.

Latest updates to the Menin Inhibitor Combo in AML Clinical Trial page
- Check6 days agoChange DetectedA new revision label v3.5.4 has been added, replacing the previous v3.5.3. This reflects a minor update to the page's revision history.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedClinicalTrials.gov’s page footer version was updated from “v3.5.2” to “v3.5.3,” indicating a site software revision/maintenance release rather than a change to the underlying trial information.SummaryDifference0.1%

- Check34 days agoChange DetectedAdded updates dated 2026-04-14, 2026-04-09, and 2026-04 with Revision: v3.5.2; removed updates dated 2025-10-23, 2025-10-21, and 2025-10 with Revision: v3.5.0.SummaryDifference0.3%

- Check48 days agoChange DetectedAdded the citation High-Throughput Proteomic Profiling to Evaluate Differentiation Syndrome With Menin Inhibition (Mol Cell Proteomics, 2026 Mar;25(3):101522) with Epub 2026-01-30. The entry previously listed 'Online ahead of print' and now reflects the official publication date.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check77 days agoChange DetectedA bibliographic citation was added with revised formatting and the study record version was updated to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Menin Inhibitor Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Menin Inhibitor Combo in AML Clinical Trial page.